Investigating MRI techniques for breast cancer treatment response
Breast Cancer Intravoxel-incoherent-motion MRI Multisite (BRIMM) Study - Resubmission - 1
This study is looking at how a special type of MRI can help us learn more about breast cancer and see how well patients respond to chemotherapy, so we can find better ways to track treatment progress for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10932384 on NIH RePORTER |
What this research studies
This research focuses on using advanced MRI technology to better understand breast cancer by analyzing various biomarkers related to tumor characteristics. It involves a multi-site approach to assess the effectiveness of intravoxel incoherent motion (IVIM) MRI in predicting how patients respond to neoadjuvant chemotherapy. By comparing data from different locations and using various software platforms, the study aims to identify reliable biomarkers that can be used across different clinical settings. Patients will be monitored over time to evaluate changes in their tumors and how these relate to treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer patients who are undergoing neoadjuvant chemotherapy.
Not a fit: Patients who are not undergoing chemotherapy or those with non-breast cancer diagnoses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for predicting treatment responses in breast cancer patients, allowing for more personalized and effective treatment plans.
How similar studies have performed: Previous studies have shown promise in using IVIM MRI for cancer assessment, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Sigmund, Eric Edward — New York University School of Medicine
- Study coordinator: Sigmund, Eric Edward
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.